Hospital Acquired Infections Therapeutic Market Size, Share & Trends Report

Hospital Acquired Infections Therapeutic Market Size, Share & Trends Analysis Report By Drug Class (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs), By Infection Type, By Region, And Segment Forecasts, 2020 - 2027

  • Report ID: GVR-4-68039-330-4
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2018
  • Industry: Healthcare

Market Segmentation

  • Hospital-acquired Infections (HAI) Therapeutics Drug Class Outlook (Revenue, USD Million, 2016 - 2027)
    • Antibacterial Drugs
      • Cell Wall Synthesis Inhibitors
      • Protein Synthesis Inhibitors
      • Others
    • Antiviral Drugs
    • Antifungal Drugs
  • Hospital-acquired Infections (HAI) Therapeutics Infection Type Outlook (Revenue, USD Million, 2016 - 2027)
    • Urinary Tract Infections
    • Ventilator-associated Pneumonia
    • Surgical Site Infections
    • Bloodstream Infections
    • Others
  • Hospital-acquired Infections (HAI) Therapeutics Regional Outlook (Revenue, USD Million, 2016 - 2027)
    • North America
      • North America Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
        • Antibacterial Drugs
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • Others
        • Antiviral Drugs
        • Antifungal Drugs
      • North America Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
        • Urinary Tract Infections
        • Ventilator-associated Pneumonia
        • Surgical Site Infections
        • Bloodstream Infections
        • Others
      • U.S.
        • U.S. Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • U.S. Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • Canada
        • Canada Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Canada Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
    • Europe
      • Europe Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
        • Antibacterial Drugs
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • Others
        • Antiviral Drugs
        • Antifungal Drugs
      • Europe Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
        • Urinary Tract Infections
        • Ventilator-associated Pneumonia
        • Surgical Site Infections
        • Bloodstream Infections
        • Others
      • U.K.
        • U.K. Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • U.K. Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • Germany
        • Germany Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Germany Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • Spain
        • Spain Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Spain Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • France
        • France Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • France Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • Italy
        • Italy Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Italy Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • Russia
        • Russia Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Russia Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
    • Asia Pacific
      • Asia Pacific Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
        • Antibacterial Drugs
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • Others
        • Antiviral Drugs
        • Antifungal Drugs
      • Asia Pacific Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
        • Urinary Tract Infections
        • Ventilator-associated Pneumonia
        • Surgical Site Infections
        • Bloodstream Infections
        • Others
      • Japan
        • Japan Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Japan Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • China
        • China Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • China Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • India
        • India Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • India Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • South Korea
        • South Korea Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • South Korea Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • Singapore
        • Singapore Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Singapore Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • Australia
        • Australia Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Australia Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
    • Latin America
      • Latin America Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
        • Antibacterial Drugs
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • Others
        • Antiviral Drugs
        • Antifungal Drugs
      • Latin America Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
        • Urinary Tract Infections
        • Ventilator-associated Pneumonia
        • Surgical Site Infections
        • Bloodstream Infections
        • Others
      • Brazil
        • Brazil Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Brazil Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • Mexico
        • Mexico Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Mexico Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • Argentina
        • Argentina Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Argentina Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
    • MEA
      • MEA Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
        • Antibacterial Drugs
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • Others
        • Antiviral Drugs
        • Antifungal Drugs
      • MEA Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
        • Urinary Tract Infections
        • Ventilator-associated Pneumonia
        • Surgical Site Infections
        • Bloodstream Infections
        • Others
      • South Africa
        • South Africa Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • South Africa Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • Saudi Arabia
        • Saudi Arabia Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • Saudi Arabia Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others
      • UAE
        • UAE Hospital-acquired Infections (HAI) Therapeutics Market, By Drug Class
          • Antibacterial Drugs
            • Cell Wall Synthesis Inhibitors
            • Protein Synthesis Inhibitors
            • Others
          • Antiviral Drugs
          • Antifungal Drugs
        • UAE Hospital-acquired Infections (HAI) Therapeutics Market, By Infection Type
          • Urinary Tract Infections
          • Ventilator-associated Pneumonia
          • Surgical Site Infections
          • Bloodstream Infections
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2016 to 2027
  • Market estimates and forecast for product segments up to 2027
  • Regional market size and forecast for product segments up to 2027
  • Market estimates and forecast for application segments up to 2027
  • Regional market size and forecast for application segments up to 2027
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon